Botanical Therapeutics for Parkinson's Disease

被引:0
作者
LI Wen-wei
机构
[1] Department of Neurology, Shanghai Public Health Clinical Center , Fudan University
[2] Department of Neurology, Zhongshan Hospital South Branch,Fudan University
[3] Institute of Neurology, Institutes of Integrative Medicine, Fudan University
基金
中国国家自然科学基金;
关键词
Parkinson’s disease; botanical therapeutics; Chinese medicine; neurotrophic activity; protein aggregation; neuroinflammation;
D O I
暂无
中图分类号
R742.5 [震颤麻痹综合征];
学科分类号
1002 ;
摘要
Parkinson’s disease(PD) was first formally described by James Parkinson in 1817, but the shaking of limbs was described in the literature of several ancient civilizations, such as ancient Chinese civilization and ancient Indian civilization. Historically, botanical drugs were used as the main source for the treatment of such kind of disorders. In Western countries, plant extracts also occupied an important place in the earlier medications of PD. With the adventure of synthetic drugs, the role of plant-derived drugs in management of PD has been diminished. Nowadays, there is still no cure for PD, dopaminergic(DA) medication is the treatment of choice, which is just designed to ameliorate symptoms of PD, and long-term use of DA medication will result in reduced efficacy and severe adverse reactions. It is necessary to explore new methods for the treatment of PD. Chinese medicine(CM) developed a holistic and unique theoretical system, and botanical drugs are widely used in practice for more than two millennia. Modern pharmacological studies have proved that Chinese herbs have potential therapeutic effects on PD, such as enhancing neurotrophic activity, clearing protein aggregates, regulating neuroinflammation, etc. All the advances provide us with hope for developing CM as a mainstream medication for treating PD.
引用
收藏
页码:405 / 411
页数:7
相关论文
共 45 条
[21]   The Medical Treatment of Parkinson Disease from James Parkinson to George Cotzias [J].
Fahn, Stanley .
MOVEMENT DISORDERS, 2015, 30 (01) :4-18
[22]  
Corynoxine, a Natural Autophagy Enhancer, Promotes the Clearance of Alpha-Synuclein via Akt/mTOR Pathway[J] . Lei-Lei Chen,Ju-Xian Song,Jia-Hong Lu,Zhen-Wei Yuan,Liang-Feng Liu,Siva Sundara Kumar Durairajan,Min Li.Journal of Neuroimmune Pharmacology . 2014 (3)
[23]  
Factors predictive of the development of levodopa‐induced dyskinesia and Wearing‐Off in Parkinson’s disease[J] . Ali H. Rajput.Mov Disord. . 2014
[24]  
Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson’s disease[J] . Navneet Khurana,Asmita Gajbhiye.Neurotoxicology . 2013
[25]  
Transient exposure to echinacoside is sufficient to activate T rk signaling and protect neuronal cells from rotenone[J] . Min Zhu,Chuanzhen Lu,Wenwei Li.J. Neurochem. . 2012 (4)
[26]   The Parkinson disease before James Parkinson [J].
Raudino, Francesco .
NEUROLOGICAL SCIENCES, 2012, 33 (04) :945-948
[27]  
Treatment of Idiopathic Parkinson’s Disease with Traditional Chinese Herbal Medicine: A Randomized Placebo-Controlled Pilot Clinical Study[J] . Wan Fung Kum,Siva Sundara Kumar Durairajan,Zhao Xiang Bian,Sui Cheung Man,Yuen Chi Lam,Li Xia Xie,Jia Hong Lu,Yan Wang,Xian Zhang Huang,Min Li.Evidence-Based Complementary and Alternative Medicine . 2011
[28]  
Neurodegeneration and Inflammation in Parkinson’s disease[J] . Sudarshan Phani,John D. Loike,Serge Przedborski.Parkinsonism and Related Disorders . 2011
[29]  
Anti-Parkinsonian drug discovery from herbal medicines: What have we got from neurotoxic models?[J] . Ju-Xian Song,Stephen Cho-Wing Sze,Tzi-Bun Ng,Caivin Kai-Fai Lee,George P.H. Leung,Pang-Chui Shaw,Yao Tong,Yan-Bo Zhang.Journal of Ethnopharmacology . 2011 (3)
[30]   CATALPOL ATTENUATES MPTP INDUCED NEURONAL DEGENERATION OF NIGRAL-STRIATAL DOPAMINERGIC PATHWAY IN MICE THROUGH ELEVATING GLIAL CELL DERIVED NEUROTROPHIC FACTOR IN STRIATUM [J].
Xu, G. ;
Xiong, Z. ;
Yong, Y. ;
Wang, Z. ;
Ke, Z. ;
Xia, Z. ;
Hu, Y. .
NEUROSCIENCE, 2010, 167 (01) :174-184